Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The pleurisy market is a specialized phase within the healthcare industry, focusing on the analysis and remedy of pleurisy, an infection of the pleura surrounding the lungs. Pleurisy is often associated with underlying conditions such as infections, autoimmune issues, or lung sicknesses, making the market dynamic and multifaceted. Market dynamics are considerably inspired by epidemiological elements related to pleurisy. The occurrence of pleurisy is related to diverse scientific conditions, and know-how of these elements is critical for developing powerful diagnostic equipment and treatment techniques. Continuous improvements in diagnostic imaging technology pressure market dynamics. High-decision imaging techniques, which include chest X-rays, computed tomography (CT) scans, and ultrasound, play a pivotal function in diagnosing pleurisy, enabling healthcare experts to visualize pleural inflammation and check its severity.
Pleuroscopy, an endoscopic procedure for analyzing the pleural cavity, impacts market dynamics. This minimally invasive method permits direct visualization, biopsy, and healing interventions, providing treasured diagnostic records and permitting centered remedies for pleurisy. Adherence to regulatory standards is vital in shaping market dynamics, especially concerning diagnostic accuracy. Diagnostic equipment and strategies for pleurisy must meet stringent regulatory requirements to ensure their protection, efficacy, and reliability in scientific exercise. Patient education and focus campaigns make contributions to market dynamics. Initiatives focused on educating each healthcare professional and the general public about the signs and symptoms, symptoms, and chance elements of pleurisy, goal to promote early reputation, well-timed intervention, and improved patient consequences. Differential prognosis challenges are a key attention in market dynamics. Pleurisy stocks symptoms with diverse respiration and cardiac situations, necessitating unique diagnostic tools and algorithms to differentiate pleuritic reasons as they should be.
Pleurisy related to autoimmune disorders influences market dynamics. Immunomodulatory remedies, together with sickness-modifying antirheumatic tablets (DMARDs) and biologics, play a role in handling autoimmune-related pleurisy and addressing the underlying immune machine disorder. Global efforts to expand the right of entry to to healthcare services impact market dynamics. Collaboration between healthcare groups, producers, and policymakers contributes to making diagnostic tools and remedies for pleurisy to be had in numerous areas, addressing worldwide fitness disparities. The integration of telemedicine and far-off consultations is a developing trend in market dynamics. Telehealth systems allow healthcare experts to remotely evaluate patients with pleuritic signs and symptoms, facilitating timely consultations and lowering the need for in-man or woman visits. Environmental issues, inclusive of air quality and occupational exposures, are rising elements in market dynamics. Efforts to address environmental factors contributing to breathing fitness issues, such as pleurisy, align with broader attention on preventive healthcare.
Pleurisy Market Highlights:
Pleurisy Market Overview
The Pleurisy market is anticipated to reach USD 3,153.3 Million by 2030 at 6.8% CAGR during the forecast period 2022-2030.Â
Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss.
Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market.
According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.
There are various causes responsible for this condition, such as rising aging population, unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of lung cancer; more than 60% of the global population smokes, this has increased the risk of lung cancer and contributed to the growth of the market.
Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing government support for the developing countries also drives the market growth.
However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.Â
Figure: Global Pleurisy Market, By Region Market Share, 2016 (%) 
Sources: Annual reports, Press release, White paper, Company presentation
Pleurisy Market Segment Insights
The pleurisy global market is segmented on the basis of diagnosis devices, treatment, and by end user.
On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.
On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others. Â
On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.
Regional Analysis
The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.
Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.
On the other hand, in the Middle East and Africa, hold the least market due to low research and development activities and poor healthcare infrastructure.
Key Players
Some of the key players in this market are: Scanlan International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan), Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas) and others.
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
 Intended Audience
- Medical Devices Manufacturers
- Government Research Laboratories
- Research and Development (R&D) Companies
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
